Encapsulation of new MPI tracer nanoparticles in the human red blood cells

Although Magnetic Particle Imaging (MPI) is not yet in clinical use, it is highly promising for several medical ap-plications, and especially for applications in diagnostic vascular in vivo imaging and imaging-guided vascular interventions. Furthermore, in the last years, different superparamagnetic iron oxide (SPIO) based contrast agents have been developed and approved for niche clinical applications in Magnetic Resonance Imaging (MRI) as alterna-tive to Gadolinium-based contrast agents (GBCAs) due to the risk for patients suffering from kidney dysfunction or nephrogenic systemic fibrosis (NSF). Recently, the potential of RBCs loaded with different SPIO nanoparticles as blood-pool tracer agents with longer blood retention time for MRI and MPI has been investigated. Here, we report the first in vitro results with the highly efficient dextran-based MPI tracer particles perimag® and synomag®-D to study their eligibility to be encapsulated into human RBCs and the potential of these new SPIO-RBC constructs as tracer material for MPI.

DDC Class

004: Informatik

610: Medizin

More Funding Information

Research funding: EuroNanoMed III, MAGneTISe project.

Publication version

publishedVersion

Lizenz

https://creativecommons.org/licenses/by/4.0/

Name

321-Article Text-1226-1-10-20200902.pdf

Size

586.64 KB

Format

Adobe PDF

Options

Encapsulation of new MPI tracer nanoparticles in the human red blood cells